Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Open in API
Filings indexed 777 across all filing types
Latest filing 2014-08-25 Legal Proceedings Report
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
Results of Mediation 1 page 196.9KB
Legal Proceedings Report Classification · 95% confidence The document is a short announcement dated 26 August 2014, reporting the results of a mediation and settlement of legal proceedings involving Cyclopharm Limited and its subsidiaries. It mentions a payment settlement and discontinuation of proceedings but does not contain financial statements, detailed financial data, or regulatory certifications. The content focuses on legal matters and settlement outcomes, which aligns with updates on significant lawsuits or regulatory actions. Given the nature and length of the document, it fits best under Legal Proceedings Report (LTR).
2014-08-25 English
Change of Director's Interest Notice 3 pages 316.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including dates, number of securities before and after the change, and nature of the transactions. This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure of insider trading activity.
2014-07-13 English
Cyclotron Facility Suffers Significant Water Damage 1
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 20 June 2014 from Cyclopharm Ltd to the Australian Securities Exchange. It reports an incident of significant water damage to the company's cyclotron facility due to a fire in the car park above. The document states that the full extent of the damage is yet to be ascertained and that updates will be provided in the future. There are no financial statements, no detailed financial data, no regulatory certifications, or voting results. The document is brief (1317 characters) and serves as an operational update to shareholders and the market about an event affecting company assets. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a regulatory filing in the sense of compliance or officer certification, but rather a general announcement about a material event. Given the lack of a more specific category, the best fit is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2014-06-19 English
Chairman's Address to Shareholders 5 pages 263.2KB
AGM Information Classification · 95% confidence The document is a detailed Chairman's Address delivered at the Annual General Meeting (AGM) of Cyclopharm Limited, dated 22 May 2014. It includes an introduction to the meeting, confirmation of quorum, overview of the company's 2013 performance, strategic updates, governance changes, and outlook. The text references the Annual Report and other documents but does not contain the full financial statements or detailed financial data itself. The content is typical of AGM presentations or speeches given during the meeting rather than a full Annual Report or financial filing. The length (over 10,000 characters) supports a substantive address rather than a brief announcement. Therefore, the document fits best under AGM Information (AGM-R), which covers presentations and materials shared during the AGM.
2014-05-21 English
Managing Director's AGM Presentation 21 pages 1.7MB
Annual Report Classification · 95% confidence The document is a detailed presentation including financial performance data, business reviews, revenue and cash flow analysis, and strategic outlook. It contains sections such as Chairman’s Address, Managing Director’s Review, financial tables with sales revenue, profit/loss before tax, cash flow, and segment performance. It also discusses business opportunities, challenges, and future plans. The presence of detailed financial data and management commentary indicates this is a comprehensive financial report for a fiscal year. The document length (10,201 characters) and content depth suggest it is not a brief announcement or a simple presentation but a full report. The content aligns with the characteristics of an Annual Report (10-K), which covers company activity and full financial performance over a year. There is no indication that this is merely an announcement of a report or a certification, nor is it a transcript, proxy statement, or other specific filing type. Therefore, the most appropriate classification is Annual Report (10-K). FY 2013
2014-05-21 English
Managing Director's Report 6 pages 363.9KB
AGM Information Classification · 95% confidence The document is a detailed address by the Managing Director at the company's Annual General Meeting (AGM), discussing the financial performance for the year 2013, segmental analysis, business outlook, and strategic updates. It includes comprehensive financial data such as revenues, net loss, segment sales, impairment charges, and operational details. The presence of a Managing Director's address at an AGM, detailed financial results for the fiscal year 2013, and discussion of business segments and outlook strongly indicate this is part of the Annual Report or AGM Information. However, the document is explicitly titled as the Managing Director's Address at the AGM and is presented as a speech or presentation at the AGM rather than the full Annual Report itself. The length (15,000 characters) and detailed financial data suggest it is more than a brief presentation but still is a speech at the AGM. According to the filing definitions, presentations and materials shared during the AGM are classified as AGM Information (AGM-R). Therefore, the document is best classified as AGM Information (AGM-R).
2014-05-21 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.